Effect of thiazolidinediones on insulin resistance and cardiovascular risk factors
The development of new, more effective ways of multivariate control of type 2 diabetes is currently the most important problem of endocrinology. This is caused by a high prevalence of this disease in the population, as well as a significant risk of complications leading to early morbidity and mortal...
Main Authors: | T Yu Demidova, E N Erokhina |
---|---|
Format: | Article |
Language: | English |
Published: |
Endocrinology Research Centre
2008-06-01
|
Series: | Ожирение и метаболизм |
Online Access: | https://www.omet-endojournals.ru/jour/article/view/6870 |
Similar Items
-
Type 2 diabetes, thiazolidinediones, and cardiovascular risk.
by: Taylor, C, et al.
Published: (2009) -
Thiazolidinedione and cardiovascular risk in type 2 diabetes mellitus
by: Yenny Yenny
Published: (2016-04-01) -
Oldies but Goodies: Thiazolidinedione as an Insulin Sensitizer with Cardioprotection
by: Eun-Hee Cho
Published: (2022-11-01) -
Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the zucker Fatty rat heart.
by: Sidell, R, et al.
Published: (2002) -
Thiazolidinedione, friend or foe?
by: Sachan A
Published: (2016-04-01)